| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.058 | 0.3 |